go-v.orgdoi

Serum-Based DNA Methylation Biomarkers in Colorectal Cancer: Potential for Screening and Early Detection

Thomas A. Summers, Russell Charles Langan, Aviram Nissan, Björn L.D.M. Brücher, Anton J. Bilchik, Mladjan Protić, Martin Däumer, Itzhak Avital, Alexander Stojadinovic · Journal of Cancer · 2013

  • DOI 10.7150/jca.5839
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2013

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2013

Abstract

Colorectal cancer (CRC) is the third most common cause of cancer-related death in the United States. Early identification and treatment of pre-cancerous colorectal lesions, or node-negative CRC are highly effective interventions that substantially reduce disease-specific mortality. Colonoscopy remains a highly effective primary screening tool based on its excellent diagnostic accuracy, and its ability to remove pre-cancerous lesions. However, the nature of the procedure limits compliance with colonoscopy intended for population-based CRC screening.

A significant advance in the screening and care of these patients could be realized by blood-based biomarkers, which could accurately identify patients at-risk for CRC development whom might benefit from early and/or more frequent surveillance for disease. We reviewed and herein discuss the potential for serum based DNA methylation biomarkers for screening and early detection of CRC.

Open the resolved locator · 10.7150/jca.5839

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:58 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v04p0210.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.